Viewing Study NCT06383533


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-02-06 @ 2:41 PM
Study NCT ID: NCT06383533
Status: RECRUITING
Last Update Posted: 2024-04-26
First Post: 2024-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module